10.1111/pan.12851 32
37 STEP-HFpEF DM specifically investigated the effect of once-weekly subcutaneous semaglutide versus placebo on the primary endpoint of change in KCCQ-CSS at 52 weeks
Its broad spectrum of biological activity has drawn significant interest within the scientific and medical communities, particularly regarding its potential use in the treatment of injuries, chronic disorders, and inflammatory conditions
Unlike tablets, injections deliver nutrients directly into your bloodstream, making them more effective in urgent or severe conditions
Hence, consult your doctor to ensure that the right supplement is being taken
Zepbound is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg injection